Aptevo Therapeutics Inc. Quarterly Operating Margin in % from Q4 2018 to Q1 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aptevo Therapeutics Inc. annual/quarterly Operating Margin history and growth rate from Q4 2018 to Q1 2022.
  • Aptevo Therapeutics Inc. Operating Margin for the quarter ending March 31, 2022 was -155 %.
  • Aptevo Therapeutics Inc. annual Operating Margin for 2022 was -920 %, a 428% decline from 2021.
  • Aptevo Therapeutics Inc. annual Operating Margin for 2021 was -174 %, a 72.7% increase from 2020.
  • Aptevo Therapeutics Inc. annual Operating Margin for 2020 was -638 %, a 405% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2022 -155 Jan 1, 2022 Mar 31, 2022
Q4 2021 -174 Oct 1, 2021 Dec 31, 2021
Q4 2019 -126 +97.7 +43.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -166 Jul 1, 2019 Sep 30, 2019
Q2 2019 -189 Apr 1, 2019 Jun 30, 2019
Q1 2019 -191 Jan 1, 2019 Mar 31, 2019
Q4 2018 -224 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.